HGS TR2J

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHGS TR2J
Drug Alias NameKMTR-2Anti-TRAIL R2 monoclonal antibodyTRAIL-R2 mAbHGS-TR2J
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonistsApoptosis stimulants
TargetsTumor necrosis factor receptor superfamily member 10B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences IncKirin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirinHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A